Anticancer Research is an independent international peer-reviewed medical journal published by the International Institute of Anticancer Research, addressing experimental and clinical topics in oncology. Issues are released monthly print and online (by Highwire Press), and an annual Index is also published. Anticancer Research was established in 1981 by John G. Delinassios.

Quick Facts Discipline, Language ...

Anticancer Research

Discipline	Oncology
Language	English
Edited by	George J. Delinasios
Publication details
History	1981–present
Publisher	International Institute of Anticancer Research (Greece)
Frequency	Monthly
Impact factor	2.480 (2020)
Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt )
ISO 4	Anticancer Res.
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus
ISSN	0250-7005 (print) 1791-7530 (web)
OCLC no.	07636918
Links
Journal homepage

Close

According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%.

According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.

Articles in Anticancer Research are abstracted and/or indexed by:

• BIOBASE
• Biological Abstracts
• CAM abstracts
• Cambridge Scientific Abstracts
• Current Contents (Life Sciences)
• EMBASE
• EMBiology
• GEOBASE
• Pubmed/Medline
• Science Citation Index
• Scopus
• Web of Science

• Official website
• International Institute of Anticancer Research

This article about an oncology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

• v
• t
• e